期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Exploiting novel molecular targets in gastrointestinal cancers 被引量:3
1
作者 wen w ma manuel Hidalgo 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第44期5845-5856,共12页
Novel molecular targets are being discovered as we learn more about the aberrant processes underlying various cancers. Efforts to translate this knowledge are starting to impact on the care of patients with gastrointe... Novel molecular targets are being discovered as we learn more about the aberrant processes underlying various cancers. Efforts to translate this knowledge are starting to impact on the care of patients with gastrointestinal cancers. The epidermal growth factor receptor (EGFR) pathway and angiogenesis have been targeted successfully in colorectal cancer with cetuximab, panitunumab and bevacizumab. Similarly, EGFR-targeting with erlotinib yielded significant survival benefit in pancreatic cancer when combined with gemcitabine. The multi-targeting approach with sorafenib has made it the first agent to achieve significant survival benefit in hepatocellular carcinoma. Efforts to exploit the dysregulated Akt/mTOR pathway in GI cancer therapy are ongoing. These molecular targets can be disrupted by various approaches, including the use of monoclonal antibody to intercept extracellular ligands and disrupt receptor-ligand binding, and small molecule inhibitors that interrupt the activation of intracellular kinases. 展开更多
关键词 COLORECTAL PANCREATIC Liver cancers Targeted therapy Epidermal growth factor receptor ROTOR ANGIOGENESIS
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部